• Avandia®
• Avandia® Death Risk
• Avandia® Heart Attack
• Avandia® Pph
• Congestive Heart Failure
• Dangers of Avandia®
• Avandia® Diabetes
• Avandia® Recall
• Avandia® Side Effects
• Avandia® Information
• Avandia® Attorneys
• Avandia® Lawyers
• Avandia® Lawsuit
• Avandia® Class Action Lawsuits
• Avandia® Litigations
• Avandia® Settlements
• Avandia® Overdose
• Avandia® & Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Since 1999, Avandia® has become one of the top-selling diabetes drugs on the market. In 2006 alone, Avandia® was prescribed to 11 million Americans. Although widely used, Avandia® carries significant risks—including an increased risk of congestive heart failure (CHF or heart failure) and a 43 percent increased risk of heart attack.

If Avandia® caused you to suffer heart attack or heart failure, let an experienced attorney evaluate your case and explain your rights—free of charge.

The Facts about Avandia® Heart Failure

• An internal Food and Drug Administration memo dated 2002 cites 25 reports of Avandia®-related heart failure that resulted in hospitalizations. At the time, FDA scientists recommended the drug's label be revised to reflect the possible risk of heart failure as revealed by post-marketing reports. It wasn't until five years later that the labeling was updated with a heightened heart warning.

• By 2007, the number of Avandia®-related heart failure cases reported to the FDA topped 680.

• A clinical trial sponsored by the drug's maker—GlaxoSmithKline—revealed that Avandia® users were more than twice as likely to develop congestive heart failure than patients using other diabetes drugs. The findings of the study were published in 2007 in the New England Journal of Medicine .

• The FDA has also received reports of anemia associated with Avandia® use. Together anemia and congestive heart failure increase a patient's risk of heart attack .

About Congestive Heart Failure

Congestive heart failure is a life-threatening condition characterized the heart's inability to pump blood efficiently, resulting in a lack of adequate oxygen supply to the body's other organs. Symptoms of congestive heart failure may include swelling in the feet and ankles, shortness of breath, loss of appetite, fatigue, weakness, and nausea, among other things.

Patients taking Avandia® who experience any symptoms of heart failure should consult with a physician as soon as possible.

Diagnosed with Heart Failure?

If so and you think Avandia® use is to blame, it is in your best interests to discuss your case with a qualified attorney. You may be entitled to compensation to cover your treatment costs as well as any other financial or emotional losses.

To arrange a complimentary consultation with an experienced Avandia® attorney, contact us today.

"FDA Announces Avandia® Label Change"

The FDA announced that is has made a change regarding cardiovascular risks to the Avandia® (rosiglitazone) label and patient Medication Guide, Feb. 4, 2011.

The FDA announcement also said that Avandia®'s drug label was updated ...

» Read More

"Risk of Death Halts Government Study"

A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.

The 10,000 patient trial was examining the effectiveness of aggressive ...

» Read More

"Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avan"

A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.

Ob...

» Read More